Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Not applicableStudy completedNCT00458926
What this trial is testing

Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care

Who this might be right for
COPDCongestive Heart FailureAsthma+2 more
Tufts Medical Center 800
Not applicableStudy completedNCT05141435
What this trial is testing

NHFOV as Primary Support in Very Preterm Infants With RDS

Who this might be right for
to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates
Jiulongpo No.1 People's Hospital 360
Not applicableStudy completedNCT05933408
What this trial is testing

TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?

Who this might be right for
Colorectal (Colon or Rectal) Cancer
Jagiellonian University 64
Large-scale testing (Phase 3)WithdrawnNCT00349518
What this trial is testing

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb
Not applicableUnknownNCT00875680
What this trial is testing

Efficacy of autoPPC for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)

Who this might be right for
Obstructive Sleep Apnea Syndrome
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche 20
Not applicableStudy completedNCT01244750
What this trial is testing

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Who this might be right for
Chronic Myeloid Leukemia
Bristol-Myers Squibb 1,494
Testing effectiveness (Phase 2)Study completedNCT00303524
What this trial is testing

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Who this might be right for
Breast Cancer
AstraZeneca 170
Large-scale testing (Phase 3)Study completedNCT03726879
What this trial is testing

Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 454
Not applicableUnknownNCT04547543
What this trial is testing

Follow-up of Apneic Patients by Visio-consultation

Who this might be right for
Obstructive Sleep Apnea
University Hospital, Grenoble 250
Large-scale testing (Phase 3)Study completedNCT01104935
What this trial is testing

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]

Who this might be right for
Breast Cancer
Comprehensive Support Project for Oncology Research 275
Large-scale testing (Phase 3)Study completedNCT00329940
What this trial is testing

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Not applicableStudy completedNCT03736382
What this trial is testing

Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaSpinal Cord Injuries
Wayne State University 47
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Testing effectiveness (Phase 2)Study completedNCT00082810
What this trial is testing

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Ended earlyNCT03913559
What this trial is testing

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 5
Next Page